INVE Aquaculture and Dalan Animal Health Collaborate to Accelerate Innovation in Shrimp Health

INVE Aquaculture and Dalan Animal Health have joined forces to tackle one of the shrimp industry's greatest challenges: disease management. The collaboration aims to accelerate the development of innovative solutions for shrimp disease prevention, addressing a critical obstacle to sustainable shrimp production worldwide. Dalan Animal Health is developing a groundbreaking vaccine technology targeting major pathogens affecting shrimp populations, including the devastating white spot syndrome virus (WSSV). INVE Aquaculture, a global leader in early-stage shrimp nutrition and health, brings over four decades of expertise in developing practical solutions for the industry.

Key Takeaways:

• Dalan Animal Health is developing a vaccine technology targeting major pathogens affecting shrimp populations, including white spot syndrome virus (WSSV).
• INVE Aquaculture brings over four decades of expertise in developing practical solutions for early-stage shrimp nutrition and health.
• The collaboration aims to accelerate the development of innovative solutions for shrimp disease prevention.
• The partnership underscores the commitment of both companies to helping shrimp farmers protect their operations and reduce the risks of disease-related losses.
• Dalan Animal Health's novel approach focuses on broodstock vaccination, representing a paradigm shift in how the industry approaches disease prevention.

Statistics:

• Over 4 decades of expertise in early-stage shrimp nutrition and health from INVE Aquaculture.
• 1 in 3 farmed shrimp worldwide is affected by disease, highlighting the need for effective disease prevention solutions.
• White spot syndrome virus (WSSV) is one of the most devastating diseases in shrimp farming.

Sources:

• INVE Aquaculture
• Dalan Animal Health
• INVE Aquaculture Press Release, October 24 (no date provided)